Wednesday, January 30, 2013

• Keryx Defies Gravityat Motley Fool (Wed, Jan 30)

Friday, January 18, 2013

• Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013Marketwired (Fri, Jan 18)

Wednesday, January 9, 2013

• Lexicon Pharmaceuticals' Management Presents at 31st Annual J.P. Morgan Healthcare Conference (Transcript)at Seeking Alpha (Wed, Jan 9)

Thursday, January 3, 2013

• Why Lexicon Pharmaceuticals Is Poised to Underperformat Motley Fool (Thu, Jan 3)
• Investors Wait On Developments For Lexicon Pharmaceuticalsat Seeking Alpha (Thu, Jan 3)

Wednesday, January 2, 2013

• Whoa! What Just Happened to My Stock?at Motley Fool (Wed, Jan 2)

Monday, December 31, 2012

• J&J Gets FDA Approval for Sirturo, Lexicon Wins Fast Track for LX1033: Healthcare Business Updateat Wall St. Cheat Sheet (Mon, Dec 31)

Wednesday, December 26, 2012

• Three Compelling Biopharma Stocks For 2013at Seeking Alpha (Wed, Dec 26)

Thursday, December 20, 2012

• Could a Virus Make You Lots of Money?at Motley Fool (Thu, Dec 20)

Wednesday, December 19, 2012

• 1 Biotech Off to the Racesat Motley Fool (Wed, Dec 19)

Tuesday, December 18, 2012

• Lexicon Pharmaceuticals IBS Drug Gets on FDA Fast Trackat Motley Fool (Tue, Dec 18)

Monday, December 17, 2012

• Why Lexicon Pharmaceuticals Fast-Tracked Higherat Motley Fool (Mon, Dec 17)
• FDA fast-tracks Lexicon Pharmaceuticals' IBS drugat bizjournals.com (Mon, Dec 17)
• Clearwire drops as reality takes holdoptionMONSTER (Mon, Dec 17)
• Lexicon drug receives fast track status from FDAAP (Mon, Dec 17)
• 3 Small Pharma Companies With Major Catalysts In 2013at Seeking Alpha (Mon, Dec 17)
• Morning Movers: Apple, Yen, Weatherford, ClearWireat Bloomberg (Mon, Dec 17)

Saturday, December 15, 2012

• The Best of 2012 #9: Hemispherx BioPharmaat Motley Fool (Sat, Dec 15)

Friday, December 7, 2012

• Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate IncreasesMarketwired (Fri, Dec 7)

Wednesday, December 5, 2012

• 3 Things to Watch at Lexiconat Motley Fool (Wed, Dec 5)

Wednesday, November 7, 2012

• Still Bullish on BioMarin, Lexicon Pharmaat TheStreet (Wed, Nov 7)
• LEXICON PHARMACEUTICALS, INC./DE Files SEC form 10-Q, Quarterly ReportEDGAR Online (Wed, Nov 7)
• Multivitamin Study Results, Vivus Craters On Q3: Healthcare Business Wrapat Wall St. Cheat Sheet (Wed, Nov 7)

Tuesday, November 6, 2012

• Lexicon Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Nov 6)
• LEXICON PHARMACEUTICALS, INC./DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatemeEDGAR Online (Tue, Nov 6)

Add LXRX News to My Yahoo!